CBAT vs ENS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

CBAT

32.6
AI Score
VS
ENS Wins

ENS

36.7
AI Score

Investment Advisor Scores

CBAT

33score
Recommendation
EXTENDED

ENS

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CBAT ENS Winner
Forward P/E 6.105 14.1844 CBAT
PEG Ratio 0 0.9459 Tie
Revenue Growth 99.3% 4.8% CBAT
Earnings Growth 15062.1% 111.6% CBAT
Tradestie Score 32.6/100 36.7/100 ENS
Profit Margin -7.4% 9.3% ENS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY CBAT

Relative Price Performance (Last 90 Days)

CBAT 1M: +30.1% · 3M: +121.3% ENS 1M: +4.7% · 3M: -8.3%

Current Technical Phase

CBAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (36.1% over 20 days), RSI 65

RSI (14): 64.9 · Price: $1.34

ENS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.8 · Price: $189.59

Fundamentals Snapshot

Metric CBAT ENS
Market Cap — —
Forward P/E 5.6 16.1
Trailing P/E — 19.5
Revenue (TTM) — —
Revenue Growth 1.0% 0.0%
Gross Margin 0.1% 0.3%
Operating Margin -0.1% 0.1%
EPS -0.17 9.40
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, ENS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.